- Home
- LOCO vs OLMA Comparison
LOCO vs OLMA Comparison
Compare LOCO & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- OLMA
- Stock Information
- Founded
- LOCO 1980
- OLMA 2006
- Country
- LOCO United States
- OLMA United States
- Employees
- LOCO N/A
- OLMA N/A
- Industry
- LOCO Restaurants
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- LOCO Consumer Discretionary
- OLMA Health Care
- Exchange
- LOCO Nasdaq
- OLMA Nasdaq
- Market Cap
- LOCO 270.6M
- OLMA 289.0M
- IPO Year
- LOCO 2014
- OLMA 2020
- Fundamental
- Price
- LOCO $10.50
- OLMA $5.28
- Analyst Decision
- LOCO Buy
- OLMA Strong Buy
- Analyst Count
- LOCO 3
- OLMA 4
- Target Price
- LOCO $15.50
- OLMA $24.50
- AVG Volume (30 Days)
- LOCO 308.1K
- OLMA 688.0K
- Earning Date
- LOCO 05-01-2025
- OLMA 05-13-2025
- Dividend Yield
- LOCO N/A
- OLMA N/A
- EPS Growth
- LOCO 6.54
- OLMA N/A
- EPS
- LOCO 0.86
- OLMA N/A
- Revenue
- LOCO $476,032,000.00
- OLMA N/A
- Revenue This Year
- LOCO $6.21
- OLMA N/A
- Revenue Next Year
- LOCO $1.20
- OLMA N/A
- P/E Ratio
- LOCO $12.24
- OLMA N/A
- Revenue Growth
- LOCO 1.22
- OLMA N/A
- 52 Week Low
- LOCO $8.29
- OLMA $2.86
- 52 Week High
- LOCO $14.25
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- LOCO 67.39
- OLMA 60.00
- Support Level
- LOCO $9.38
- OLMA $4.80
- Resistance Level
- LOCO $9.93
- OLMA $5.61
- Average True Range (ATR)
- LOCO 0.32
- OLMA 0.38
- MACD
- LOCO 0.15
- OLMA 0.02
- Stochastic Oscillator
- LOCO 94.77
- OLMA 78.71
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.